An illustration of a magnifying glass. An illustration of a magnifying glass.
The company’s backlog rose significantly in the fourth quarter, reaching approximately $30 billion, which underscores its diversified portfolio and suggests potential for recovery in the future.
ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...
DUBLIN, January 30, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of ...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI ...
NEW YORK (Reuters) - Foreign investors added $273.5 billion to their emerging market equity and debt portfolios last year, nearly $100 billion more than in 2023, according to a bank trade group's ...
Climate tech fund Regeneration.VC, which is backed by Leonardo DiCaprio as a limited partner, has taken over the management of Sky Ocean Ventures' climate portfolio. Launched in 2022, Regeneration ...